Filing Flows › Arcus Biosciences (RCUS) › Other collaboration revenue
Arcus Biosciences (RCUS) Other collaboration revenue by quarter
Arcus Biosciences' Other collaboration revenue was $1.0M in Q3 2026 (third quarter 2026), -96% from Q2 2026. Over the last 5 quarters it ranged from $1.0M (Q3 2026) to $25.0M (Q2 2026).
| Quarter | Other collaboration revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $1.0M | -96% | -83% |
| Q2 2026 | $25.0M | +400% | — |
| Q1 2026 | $5.0M | -17% | -38% |
| Q3 2025 | $6.0M | -25% | — |
| Q1 2025 | $8.0M | — | — |
Q3 2026 at a glance
Arcus Biosciences, Q3 2026: revenue $9.0M (-65% year over year), net loss $128M, operating cash flow −$88.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Arcus Biosciences' Other collaboration revenue?
Arcus Biosciences' Other collaboration revenue was $1.0M in Q3 2026 (third quarter 2026), -96% from Q2 2026.
How has Arcus Biosciences' Other collaboration revenue changed?
Over the last 5 quarters it ranged from $1.0M (Q3 2026) to $25.0M (Q2 2026).